Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

DDogwood Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
D

Dogwood Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
    Sep 14, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026
    Aug 17, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
    Aug 13, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
    Jul 20, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
    Jun 30, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study
    May 18, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Therapeutics Announces First Quarter 2026 Financial Results
    May 14, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
    May 7, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
    Apr 23, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
    Apr 15, 2026Dogwood Therapeutics, Inc. (DWTX) Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions